{"id": "article-23222_0", "title": "Malignant Hypertension -- Continuing Education Activity", "content": "Malignant hypertension is a term that has been used to describe patients with elevated blood pressure (BP) and multiple complications with poor prognoses. Today, the term hypertensive crisis is used to describe patients who present with severe BP elevations as follows: Systolic blood pressure and (SBP) greater than 180 mm Hg and Diastolic blood pressure (DBP) greater than 120 mm Hg). The diagnosis can be further classified as a hypertensive emergency when severe elevation in BP is associated with end-organ damage or hypertensive urgency when severe hypertension occurs without it. This activity reviews the cause of malignant hypertension, its pathophysiology and highlights the role of the interprofessional team in its management.", "contents": "Malignant Hypertension -- Continuing Education Activity. Malignant hypertension is a term that has been used to describe patients with elevated blood pressure (BP) and multiple complications with poor prognoses. Today, the term hypertensive crisis is used to describe patients who present with severe BP elevations as follows: Systolic blood pressure and (SBP) greater than 180 mm Hg and Diastolic blood pressure (DBP) greater than 120 mm Hg). The diagnosis can be further classified as a hypertensive emergency when severe elevation in BP is associated with end-organ damage or hypertensive urgency when severe hypertension occurs without it. This activity reviews the cause of malignant hypertension, its pathophysiology and highlights the role of the interprofessional team in its management."}
{"id": "article-23222_1", "title": "Malignant Hypertension -- Continuing Education Activity", "content": "Objectives: Outline the causes of malignant hypertension. Describe the presentation of a patient with malignant hypertension. Summarize the treatment of malignant hypertension. Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by malignant hypertension. Access free multiple choice questions on this topic.", "contents": "Malignant Hypertension -- Continuing Education Activity. Objectives: Outline the causes of malignant hypertension. Describe the presentation of a patient with malignant hypertension. Summarize the treatment of malignant hypertension. Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by malignant hypertension. Access free multiple choice questions on this topic."}
{"id": "article-23222_2", "title": "Malignant Hypertension -- Introduction", "content": "Malignant hypertension is a term that has been\u00a0used to describe patients with elevated blood pressure (BP) and multiple complications (End organ damage) with a poor prognosis. Today, the term hypertensive crisis is used\u00a0to describe patients who present with severe BP elevations as follow: Systolic blood pressure (SBP) greater than 180 mm Hg Diastolic blood pressure (DBP)\u00a0greater\u00a0than 120 mm Hg)", "contents": "Malignant Hypertension -- Introduction. Malignant hypertension is a term that has been\u00a0used to describe patients with elevated blood pressure (BP) and multiple complications (End organ damage) with a poor prognosis. Today, the term hypertensive crisis is used\u00a0to describe patients who present with severe BP elevations as follow: Systolic blood pressure (SBP) greater than 180 mm Hg Diastolic blood pressure (DBP)\u00a0greater\u00a0than 120 mm Hg)"}
{"id": "article-23222_3", "title": "Malignant Hypertension -- Introduction", "content": "The diagnosis can be further classified as a hypertensive emergency when severe elevation in\u00a0BP is associated with end-organ damage or hypertensive urgency when severe hypertension occurs without it. Prompt treatment of\u00a0BP can prevent a hypertensive emergency and, consequently,\u00a0serious life-threatening complications. [1] [2] [3] [4] To make a diagnosis of malignant hypertension, papilledema has to be present. In malignant hypertension, the key is to lower the blood pressure within a few hours.", "contents": "Malignant Hypertension -- Introduction. The diagnosis can be further classified as a hypertensive emergency when severe elevation in\u00a0BP is associated with end-organ damage or hypertensive urgency when severe hypertension occurs without it. Prompt treatment of\u00a0BP can prevent a hypertensive emergency and, consequently,\u00a0serious life-threatening complications. [1] [2] [3] [4] To make a diagnosis of malignant hypertension, papilledema has to be present. In malignant hypertension, the key is to lower the blood pressure within a few hours."}
{"id": "article-23222_4", "title": "Malignant Hypertension -- Etiology", "content": "There are multiple causes of malignant hypertension (hypertensive crisis), including the following: Medication noncompliance Renovascular diseases, such as renal artery stenosis, polyarteritis nodosa, and Takayasu arteritis Renal parenchymal disease including glomerulonephritis, tubulointerstitial nephritis, systemic sclerosis, hemolytic-uremic syndrome, systemic lupus erythematosus Endocrine dysfunction, such as pheochromocytoma, Cushing disease, primary hyperaldosteronism, renin-secreting tumor Coarctation of aorta; drugs or other exposures, including cocaine, phencyclidine, sympathomimetics, erythropoietin, cyclosporine Antihypertensive medication withdrawal Amphetamines Central nervous system disorders, such as head injury, cerebral infarction, and cerebral hemorrhage", "contents": "Malignant Hypertension -- Etiology. There are multiple causes of malignant hypertension (hypertensive crisis), including the following: Medication noncompliance Renovascular diseases, such as renal artery stenosis, polyarteritis nodosa, and Takayasu arteritis Renal parenchymal disease including glomerulonephritis, tubulointerstitial nephritis, systemic sclerosis, hemolytic-uremic syndrome, systemic lupus erythematosus Endocrine dysfunction, such as pheochromocytoma, Cushing disease, primary hyperaldosteronism, renin-secreting tumor Coarctation of aorta; drugs or other exposures, including cocaine, phencyclidine, sympathomimetics, erythropoietin, cyclosporine Antihypertensive medication withdrawal Amphetamines Central nervous system disorders, such as head injury, cerebral infarction, and cerebral hemorrhage"}
{"id": "article-23222_5", "title": "Malignant Hypertension -- Epidemiology", "content": "Hypertensive emergencies are unusual, with a projected incidence of 1 to 2 cases per million per year. However, a recent investigation showed that the estimated number of visits due to this condition and the rate per million per adult emergency department (ED) visits have more than doubled from 2006 to 2013. Few examples include eclampsia (2%), cerebral infarction (39%), and acute pulmonary edema (25%).", "contents": "Malignant Hypertension -- Epidemiology. Hypertensive emergencies are unusual, with a projected incidence of 1 to 2 cases per million per year. However, a recent investigation showed that the estimated number of visits due to this condition and the rate per million per adult emergency department (ED) visits have more than doubled from 2006 to 2013. Few examples include eclampsia (2%), cerebral infarction (39%), and acute pulmonary edema (25%)."}
{"id": "article-23222_6", "title": "Malignant Hypertension -- Pathophysiology", "content": "Hypertensive emergencies occur when a relatively rapid elevation of\u00a0BP develops in a short period. An increase in systemic vascular resistance by increasing vasoconstriction mechanisms through renin-angiotensin activation, pressure natriuresis, hypoperfusion, and ischemia are the most common culprits of end-organ damage. The classic vascular feature is fibrinoid necrosis of the small vessels. In addition, red cell destruction is common as they pass through these obstructed vessels leading to microangiopathic hemolytic anemia. Another feature of a hypertensive emergency is the loss of autoregulation in the brain, which can present as hypertensive encephalopathy.", "contents": "Malignant Hypertension -- Pathophysiology. Hypertensive emergencies occur when a relatively rapid elevation of\u00a0BP develops in a short period. An increase in systemic vascular resistance by increasing vasoconstriction mechanisms through renin-angiotensin activation, pressure natriuresis, hypoperfusion, and ischemia are the most common culprits of end-organ damage. The classic vascular feature is fibrinoid necrosis of the small vessels. In addition, red cell destruction is common as they pass through these obstructed vessels leading to microangiopathic hemolytic anemia. Another feature of a hypertensive emergency is the loss of autoregulation in the brain, which can present as hypertensive encephalopathy."}
{"id": "article-23222_7", "title": "Malignant Hypertension -- History and Physical", "content": "Most patients have persistently elevated BP for years before presenting with the hypertensive emergency. Initial questioning should focus on finding indicators related to end-organ damage, including headaches, nausea or vomiting, visual disturbances, chest or back pain, dyspnea, orthopnea, or visual disturbances. Review all prescription and nonprescription medications, adherence, and time from the last dose. Ask about recreational drug use, such as amphetamines, cocaine, phencyclidine.", "contents": "Malignant Hypertension -- History and Physical. Most patients have persistently elevated BP for years before presenting with the hypertensive emergency. Initial questioning should focus on finding indicators related to end-organ damage, including headaches, nausea or vomiting, visual disturbances, chest or back pain, dyspnea, orthopnea, or visual disturbances. Review all prescription and nonprescription medications, adherence, and time from the last dose. Ask about recreational drug use, such as amphetamines, cocaine, phencyclidine."}
{"id": "article-23222_8", "title": "Malignant Hypertension -- History and Physical", "content": "On physical exam, confirm\u00a0BP on both arms using an appropriately-sized blood pressure cuff. Funduscopic exam findings may include hemorrhages, exudates, or papilledema. Assess for murmurs and gallops or other signs of heart failure. Look for evidence of pulmonary edema, abdominal bruits. Neurological findings can include stupor, seizures, delirium, agitation. [5] [6] [7]", "contents": "Malignant Hypertension -- History and Physical. On physical exam, confirm\u00a0BP on both arms using an appropriately-sized blood pressure cuff. Funduscopic exam findings may include hemorrhages, exudates, or papilledema. Assess for murmurs and gallops or other signs of heart failure. Look for evidence of pulmonary edema, abdominal bruits. Neurological findings can include stupor, seizures, delirium, agitation. [5] [6] [7]"}
{"id": "article-23222_9", "title": "Malignant Hypertension -- Evaluation", "content": "The history and physical examination are really important in patients presenting with a very elevated BP or an acute rise over a previously normal baseline, even if the presenting\u00a0BP is less than 180/120 mm Hg. Furthermore, the following evaluation should be performed to find the presence of end-organ damage in association with targeted clinical symptoms or signs: Electrocardiography Chest x-Ray Urinalysis Electrolytes and creatinine Cardiac biomarkers, when the acute coronary syndrome is suspected Toxicology screen CT/MRI of the brain,\u00a0when head injury, neurologic symptoms, hypertensive retinopathy, nausea, or vomiting are present Contrast CT/MRI of the chest or TEE, if aortic dissection is suspected", "contents": "Malignant Hypertension -- Evaluation. The history and physical examination are really important in patients presenting with a very elevated BP or an acute rise over a previously normal baseline, even if the presenting\u00a0BP is less than 180/120 mm Hg. Furthermore, the following evaluation should be performed to find the presence of end-organ damage in association with targeted clinical symptoms or signs: Electrocardiography Chest x-Ray Urinalysis Electrolytes and creatinine Cardiac biomarkers, when the acute coronary syndrome is suspected Toxicology screen CT/MRI of the brain,\u00a0when head injury, neurologic symptoms, hypertensive retinopathy, nausea, or vomiting are present Contrast CT/MRI of the chest or TEE, if aortic dissection is suspected"}
{"id": "article-23222_10", "title": "Malignant Hypertension -- Evaluation", "content": "It is often easiest to categorize hypertensive emergencies by the organ that is being damaged. The evaluation above can usually identify the at-risk target organ and direct both the target\u00a0BP and the promptness with which the target is achieved.", "contents": "Malignant Hypertension -- Evaluation. It is often easiest to categorize hypertensive emergencies by the organ that is being damaged. The evaluation above can usually identify the at-risk target organ and direct both the target\u00a0BP and the promptness with which the target is achieved."}
{"id": "article-23222_11", "title": "Malignant Hypertension -- Evaluation", "content": "The cardiac exam may reveal the presence of an MI, CHF, or pulmonary edema. Concentric left ventricular hypertrophy is often present, including the 4th heart sound. Always check the blood pressure in both arms to rule out aortic dissection. Patients may also have bruit in the neck and groin. CNS exam may reveal a headache, visual changes, vomiting, confusion, and seizures. The eye exam may reveal soft exudates, flame-shaped hemorrhages, and papilledema. The renal exam may present with oliguria, and the GI symptoms may include nausea, vomiting, and vague abdominal pain.", "contents": "Malignant Hypertension -- Evaluation. The cardiac exam may reveal the presence of an MI, CHF, or pulmonary edema. Concentric left ventricular hypertrophy is often present, including the 4th heart sound. Always check the blood pressure in both arms to rule out aortic dissection. Patients may also have bruit in the neck and groin. CNS exam may reveal a headache, visual changes, vomiting, confusion, and seizures. The eye exam may reveal soft exudates, flame-shaped hemorrhages, and papilledema. The renal exam may present with oliguria, and the GI symptoms may include nausea, vomiting, and vague abdominal pain."}
{"id": "article-23222_12", "title": "Malignant Hypertension -- Treatment / Management", "content": "Adequate therapy, including the choice of the medication and the\u00a0BP target, changes depending on the specific hypertensive emergency and the affected organ. [8] [9] [10] [11]", "contents": "Malignant Hypertension -- Treatment / Management. Adequate therapy, including the choice of the medication and the\u00a0BP target, changes depending on the specific hypertensive emergency and the affected organ. [8] [9] [10] [11]"}
{"id": "article-23222_13", "title": "Malignant Hypertension -- Treatment / Management", "content": "It is not recommended to decrease the BP too fast or too much, as ischemic damage can occur in vascular territories that have become habituated with the elevated level of BP. However, for most hypertensive emergencies, mean arterial pressure (MAP) should be reduced by approximately 10 to 20%\u00a0within\u00a0the first hour and by another 5% to 15% over the next 24 hours. This often results in a target\u00a0BP of less than 180/120 mm Hg for the first hour and less than 160/110 mm Hg for the next 24 hours, but rarely less than 130/80 mm Hg during that time frame. Common intravenous (IV) medications and doses used to treat hypertensive emergencies include:", "contents": "Malignant Hypertension -- Treatment / Management. It is not recommended to decrease the BP too fast or too much, as ischemic damage can occur in vascular territories that have become habituated with the elevated level of BP. However, for most hypertensive emergencies, mean arterial pressure (MAP) should be reduced by approximately 10 to 20%\u00a0within\u00a0the first hour and by another 5% to 15% over the next 24 hours. This often results in a target\u00a0BP of less than 180/120 mm Hg for the first hour and less than 160/110 mm Hg for the next 24 hours, but rarely less than 130/80 mm Hg during that time frame. Common intravenous (IV) medications and doses used to treat hypertensive emergencies include:"}
{"id": "article-23222_14", "title": "Malignant Hypertension -- Treatment / Management", "content": "Nicardipine, initial infusion rate 5 mg per hour, increasing by 2.5 mg per hour every 5 minutes to a maximum of 15 mg per hour Sodium nitroprusside, 0.3 to 0.5 mcg/kg/minute, increases by 0.5 mcg/kg\u00a0per\u00a0minute every few minutes as needed to a maximum dose of 10 mcg/kg\u00a0per\u00a0minute. Labetalol 10 to 20 mg IV followed by bolus doses of 20 to 80 mg at 10-minute intervals until a target blood pressure is reached to a maximum 300-mg cumulative dose Esmolol, initial loading dose 500 mcg/kg/minute over 1 minute, then 50 to 100 mcg/kg/minute to a maximum dose of 300 mcg/kg per minute.", "contents": "Malignant Hypertension -- Treatment / Management. Nicardipine, initial infusion rate 5 mg per hour, increasing by 2.5 mg per hour every 5 minutes to a maximum of 15 mg per hour Sodium nitroprusside, 0.3 to 0.5 mcg/kg/minute, increases by 0.5 mcg/kg\u00a0per\u00a0minute every few minutes as needed to a maximum dose of 10 mcg/kg\u00a0per\u00a0minute. Labetalol 10 to 20 mg IV followed by bolus doses of 20 to 80 mg at 10-minute intervals until a target blood pressure is reached to a maximum 300-mg cumulative dose Esmolol, initial loading dose 500 mcg/kg/minute over 1 minute, then 50 to 100 mcg/kg/minute to a maximum dose of 300 mcg/kg per minute."}
{"id": "article-23222_15", "title": "Malignant Hypertension -- Treatment / Management", "content": "If there is any possibility of over or underestimating\u00a0BP using frequent noninvasive cuff measurements or if the end-organ damage is life-threatening, consider arterial catheterization for precise, second-to-second measurements allowing for more careful medication titration. The major exceptions to gradual\u00a0BP lowering over the first day are:", "contents": "Malignant Hypertension -- Treatment / Management. If there is any possibility of over or underestimating\u00a0BP using frequent noninvasive cuff measurements or if the end-organ damage is life-threatening, consider arterial catheterization for precise, second-to-second measurements allowing for more careful medication titration. The major exceptions to gradual\u00a0BP lowering over the first day are:"}
{"id": "article-23222_16", "title": "Malignant Hypertension -- Treatment / Management", "content": "A cute phase of an ischemic CVA: The BP is usually not treated unless it is greater than 185/110 mmHg in patients whose reperfusion therapy could be an option or greater than 220/120 mm Hg in patients who\u00a0might not qualify\u00a0for it. Consider labetalol or nicardipine infusion. A cute aortic dissection: The\u00a0SBP should be lowered to 120 mm Hg within\u00a020 minutes, and a target heart rate\u00a0around\u00a060 beats per minute to reduce aortic shearing forces. Treatment usually requires a beta-blocker and a vasodilator. Options include esmolol, nicardipine, or nitroprusside. A n intracerebral hemorrhage: The goals of therapy are different and depend on the location and surgical approach. A cute myocardial ischemia: Nitroglycerin is the drug of choice; do not use if the patient has taken phosphodiesterase inhibitors, including sildenafil or tadalafil, within the past 48 hours.", "contents": "Malignant Hypertension -- Treatment / Management. A cute phase of an ischemic CVA: The BP is usually not treated unless it is greater than 185/110 mmHg in patients whose reperfusion therapy could be an option or greater than 220/120 mm Hg in patients who\u00a0might not qualify\u00a0for it. Consider labetalol or nicardipine infusion. A cute aortic dissection: The\u00a0SBP should be lowered to 120 mm Hg within\u00a020 minutes, and a target heart rate\u00a0around\u00a060 beats per minute to reduce aortic shearing forces. Treatment usually requires a beta-blocker and a vasodilator. Options include esmolol, nicardipine, or nitroprusside. A n intracerebral hemorrhage: The goals of therapy are different and depend on the location and surgical approach. A cute myocardial ischemia: Nitroglycerin is the drug of choice; do not use if the patient has taken phosphodiesterase inhibitors, including sildenafil or tadalafil, within the past 48 hours."}
{"id": "article-23222_17", "title": "Malignant Hypertension -- Treatment / Management", "content": "After a suitable period, often 8 to 24 hours, of\u00a0BP control at a target, oral medications are usually given, and the initial intravenous therapy is tapered and discontinued.", "contents": "Malignant Hypertension -- Treatment / Management. After a suitable period, often 8 to 24 hours, of\u00a0BP control at a target, oral medications are usually given, and the initial intravenous therapy is tapered and discontinued."}
{"id": "article-23222_18", "title": "Malignant Hypertension -- Differential Diagnosis", "content": "Acute kidney injury Aortic coarctation Aortic dissection Chronic kidney disease Eclampsia Hypercalcemia Hyperthyroidism Pheochromocytoma Renal artery stenosis Subarachnoid hemorrhage", "contents": "Malignant Hypertension -- Differential Diagnosis. Acute kidney injury Aortic coarctation Aortic dissection Chronic kidney disease Eclampsia Hypercalcemia Hyperthyroidism Pheochromocytoma Renal artery stenosis Subarachnoid hemorrhage"}
{"id": "article-23222_19", "title": "Malignant Hypertension -- Staging", "content": "ACEP Guidelines for managing hypertension in the ED In asymptomatic patients with elevated BP, routine screening for end-organ damage is not recommended. In select patients (poor follow-up) screening for elevated creatinine may identify the renal injury. In asymptomatic patients with elevated BP, immediate medical intervention is not necessary. Selected patients with poor follow-up can be treated in the ED for elevated blood pressure. All patients with asymptomatic elevated BP should be referred to a cardiology outpatient clinic.", "contents": "Malignant Hypertension -- Staging. ACEP Guidelines for managing hypertension in the ED In asymptomatic patients with elevated BP, routine screening for end-organ damage is not recommended. In select patients (poor follow-up) screening for elevated creatinine may identify the renal injury. In asymptomatic patients with elevated BP, immediate medical intervention is not necessary. Selected patients with poor follow-up can be treated in the ED for elevated blood pressure. All patients with asymptomatic elevated BP should be referred to a cardiology outpatient clinic."}
{"id": "article-23222_20", "title": "Malignant Hypertension -- Prognosis", "content": "The prognosis of patients with malignant hypertension is guarded. Five-year survivals of 75% to 84% have been reported with treatment; without treatment, the life expectancy is less than 24 months. Most deaths are a result of heart failure, stroke, or renal failure.", "contents": "Malignant Hypertension -- Prognosis. The prognosis of patients with malignant hypertension is guarded. Five-year survivals of 75% to 84% have been reported with treatment; without treatment, the life expectancy is less than 24 months. Most deaths are a result of heart failure, stroke, or renal failure."}
{"id": "article-23222_21", "title": "Malignant Hypertension -- Complications", "content": "Multiple complications can arise when target organs are affected, including encephalopathy, intracerebral hemorrhage, acute myocardial infarction, acute heart failure, pulmonary edema, unstable angina, dissecting aortic aneurysm, acute kidney injury, and vision loss.", "contents": "Malignant Hypertension -- Complications. Multiple complications can arise when target organs are affected, including encephalopathy, intracerebral hemorrhage, acute myocardial infarction, acute heart failure, pulmonary edema, unstable angina, dissecting aortic aneurysm, acute kidney injury, and vision loss."}
{"id": "article-23222_22", "title": "Malignant Hypertension -- Pearls and Other Issues", "content": "Most patients with\u00a0severely elevated\u00a0BP have no acute end-organ damage (hypertensive urgency). Nevertheless, some patients have signs and symptoms of acute, ongoing injury, which is recognized as\u00a0hypertensive emergency or formerly as malignant hypertension.", "contents": "Malignant Hypertension -- Pearls and Other Issues. Most patients with\u00a0severely elevated\u00a0BP have no acute end-organ damage (hypertensive urgency). Nevertheless, some patients have signs and symptoms of acute, ongoing injury, which is recognized as\u00a0hypertensive emergency or formerly as malignant hypertension."}
{"id": "article-23222_23", "title": "Malignant Hypertension -- Pearls and Other Issues", "content": "It is generally not recommended to decrease the BP too quickly or too much as ischemic damage can occur in vascular territories that have become habituated with the elevated level of BP. For most hypertensive emergencies, the MAP\u00a0should be reduced gradually by approximately 10 to 20%\u00a0within\u00a0the first hour and by a further 5% to 15% over the next 24 hours, with a final goal of approximately 25% reduction compared with baseline. Many patients have poorly controlled essential or secondary hypertension. Thus, long-term management turns out to be the primacy once the hypertensive crisis has been addressed.", "contents": "Malignant Hypertension -- Pearls and Other Issues. It is generally not recommended to decrease the BP too quickly or too much as ischemic damage can occur in vascular territories that have become habituated with the elevated level of BP. For most hypertensive emergencies, the MAP\u00a0should be reduced gradually by approximately 10 to 20%\u00a0within\u00a0the first hour and by a further 5% to 15% over the next 24 hours, with a final goal of approximately 25% reduction compared with baseline. Many patients have poorly controlled essential or secondary hypertension. Thus, long-term management turns out to be the primacy once the hypertensive crisis has been addressed."}
{"id": "article-23222_24", "title": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes", "content": "The management of malignant hypertension requires an interprofessional team that includes an internist, nephrologist, cardiologist, and neurologist. Untreated, elevated blood pressure has high morbidity and mortality, including enormous healthcare costs. Therefore, the primary care providers, including the nurse practitioner, should regularly monitor blood pressure and emphasize medication compliance. For asymptomatic patients, admission is not recommended. However, those with symptoms need to be monitored, and the specialists consulted to determine the presence of end-organ injury.", "contents": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes. The management of malignant hypertension requires an interprofessional team that includes an internist, nephrologist, cardiologist, and neurologist. Untreated, elevated blood pressure has high morbidity and mortality, including enormous healthcare costs. Therefore, the primary care providers, including the nurse practitioner, should regularly monitor blood pressure and emphasize medication compliance. For asymptomatic patients, admission is not recommended. However, those with symptoms need to be monitored, and the specialists consulted to determine the presence of end-organ injury."}
{"id": "article-23222_25", "title": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes", "content": "It is not recommended to decrease the BP too fast or too low, as ischemic damage can occur in vascular territories that have become habituated with the elevated level of BP. However, for the majority of hypertensive emergencies, mean arterial pressure (MAP) should be reduced by approximately 10% to 20%\u00a0within\u00a0the first hour and by another 5% to 15% over the next 24 hours.", "contents": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes. It is not recommended to decrease the BP too fast or too low, as ischemic damage can occur in vascular territories that have become habituated with the elevated level of BP. However, for the majority of hypertensive emergencies, mean arterial pressure (MAP) should be reduced by approximately 10% to 20%\u00a0within\u00a0the first hour and by another 5% to 15% over the next 24 hours."}
{"id": "article-23222_26", "title": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes", "content": "All patients with hypertension should be encouraged to follow up in the outpatient clinic with a cardiology nurse. In addition, adherence to a low salt diet is beneficial. Finally, the interprofessional team members should continually encourage patients to remain compliant with their blood pressure medications and monitor their blood pressure at home.", "contents": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes. All patients with hypertension should be encouraged to follow up in the outpatient clinic with a cardiology nurse. In addition, adherence to a low salt diet is beneficial. Finally, the interprofessional team members should continually encourage patients to remain compliant with their blood pressure medications and monitor their blood pressure at home."}
{"id": "article-23222_27", "title": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes -- Outcomes", "content": "The outcome for most patients with malignant hypertension in the short term is good, but in the long term, exacerbations are common. Strokes, vision loss, kidney damage, and adverse cardiac events are known to occur in a number of patients who are not compliant with therapy. [12] [Level V]", "contents": "Malignant Hypertension -- Enhancing Healthcare Team Outcomes -- Outcomes. The outcome for most patients with malignant hypertension in the short term is good, but in the long term, exacerbations are common. Strokes, vision loss, kidney damage, and adverse cardiac events are known to occur in a number of patients who are not compliant with therapy. [12] [Level V]"}
{"id": "article-23222_28", "title": "Malignant Hypertension -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Malignant Hypertension -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}